• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOVENTUS LLC DUROLANE (HYALURONIC ACID) INJECTION; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOVENTUS LLC DUROLANE (HYALURONIC ACID) INJECTION; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Lot Number 21934
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/17/2024
Event Type  malfunction  
Event Description
Durolane (hyaluronic acid) 60mg/3 ml syringe was defective.Provide pulled cap off and the needle hub came off with at the same time, so needle could not be put on the syringe.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DUROLANE (HYALURONIC ACID) INJECTION
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
BIOVENTUS LLC
MDR Report Key19152354
MDR Text Key341001299
Report NumberMW5154030
Device Sequence Number1
Product Code MOZ
UDI-Device Identifier89130-2020-1
UDI-Public89130-2020-1
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Pharmacist
Type of Report Initial
Report Date 04/17/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Lot Number21934
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received04/19/2024
Patient Sequence Number1
-
-